Skip to content

Clinical trials

Phase 2 Rheumatic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rheumatic Diseases Phase: Phase 2 Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20093
20111
20132
20152
20161
20191
20201
20211
20223
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated5
Unknown status2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lakefront Biotherapeutics NV2
Novartis Pharmaceuticals2
AbbVie1
Amgen1
Bioxtract SA1
Cara Therapeutics, Inc.1
Eli Lilly and Company1
Levicept1
NYU Langone Health1
Olatec Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rheumatic Diseases19
Arthritis10
Joint Diseases10
Musculoskeletal Diseases9
Arthritis, Rheumatoid7
Autoimmune Diseases7
Osteoarthritis5
Connective Tissue Diseases4
Osteoarthritis, Knee4
Arthritis, Psoriatic3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.